Mission BioCapital
Venture capital · Cambridge, Massachusetts, United States
Portfolio collected from the firm’s website, last checked Jul 26, 2026.Raises and exits come from each company’s own SEC and company records.
9Deep-tech portfolio5 active
4Portfolio exitsAcquired or listed
1Raises, 12 monthsLatest: Memento Medicines
28Co-investorsShare a portfolio company
Portfolio companies’ first raises and first grants, by year
First raisesFirst federal grants
The year each portfolio company first filed a Form D, and first won a federal grant. These describe the companies, not when this investor joined them.
Portfolio · 9 companies
| Company | Sector | Status | Latest raise | Raised |
|---|---|---|---|---|
| Memento Medicines | Biotech | Active | Jun 16, 2026 | $38.0M |
| Sana Biotechnology | Biotech | Active | Jun 26, 2020 | $866.9M |
| Appia Bio | Biotech | Active | — | — |
| Maze Therapeutics | Biotech | Active | — | — |
| Normunity | Biotech | Active | — | — |
| Cargo Therapeutics | Biotech | Acquired | Mar 1, 2023 | $68.8M |
| Imago BioSciences | Biotech | Acquired | Nov 20, 2020 | $105.8M |
| Jasper Therapeutics | Biotech | Public | — | — |
| Prime Medicine | Biotech | Public | — | — |
Peer ranks
Portfolio size#52
Portfolio exits#49
Raises, 12 months#22
Co-investors#64
Co-investors
- ARCH VentureVenture capital4 shared
- RA CapitalVenture capital2 shared
- Third Rock VenturesVenture capital2 shared
- Alloy TherapeuticsVenture capital1 shared
- AmazonVenture capital1 shared
- Astellas Venture ManagementVenture capital1 shared
- Atlas VentureVenture capital1 shared
- Biotechnology Value FundVenture capital1 shared
- Brookside CapitalVenture capital1 shared
- EcoR1 CapitalVenture capital1 shared
Sectors
- Biotech9
Portfolios are collected from investors’ own websites and matched to tracked deep-tech companies by name; duplicate listings of the same firm are merged. Exits and raises come from each company’s own record: Form D through the latest filing.